Growing community of inventors

Malnate, Italy

Luigi Molteni

Average Co-Inventor Count = 3.33

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 24

Luigi MolteniMassimo Signorini (1 patent)Luigi MolteniEraldo Antonini (1 patent)Luigi MolteniFranco Bolasco (1 patent)Luigi MolteniAdriana Memoli (1 patent)Luigi MolteniClaudio Botre (1 patent)Luigi MolteniJose A Ramirez Fernandez (1 patent)Luigi MolteniFranco Montrone (1 patent)Luigi MolteniFranco Scrollini (1 patent)Luigi MolteniInnocenzo Caruso (1 patent)Luigi MolteniGian Piero Vercesi (1 patent)Luigi MolteniGiampiero Vercesi (1 patent)Luigi MolteniAttilio Trebbi (1 patent)Luigi MolteniLuigi Molteni (5 patents)Massimo SignoriniMassimo Signorini (6 patents)Eraldo AntoniniEraldo Antonini (4 patents)Franco BolascoFranco Bolasco (2 patents)Adriana MemoliAdriana Memoli (1 patent)Claudio BotreClaudio Botre (1 patent)Jose A Ramirez FernandezJose A Ramirez Fernandez (1 patent)Franco MontroneFranco Montrone (1 patent)Franco ScrolliniFranco Scrollini (1 patent)Innocenzo CarusoInnocenzo Caruso (1 patent)Gian Piero VercesiGian Piero Vercesi (1 patent)Giampiero VercesiGiampiero Vercesi (1 patent)Attilio TrebbiAttilio Trebbi (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Dr. L. Zambeletti Spa (2 from 5 patents)

2. Dr. Lo. Zambeletti S.p.a. (1 from 12 patents)

3. Zambeletti Espana, S.a. (1 from 1 patent)

4. Dr. L. .degree. Zambeletti S.p.a. (1 from 1 patent)


5 patents:

1. 4408074 - Process for preparing 1-(3,5-dimethoxy-4-hydroxy

2. 4312866 - Use of rifamycin SV and its related salts in the treatment of rheumatoid

3. 4192894 - Compound with disinfectant activity and pharmaceutical compositions

4. 4125616 - Pyridoxylidine amino benzoate compounds

5. 4048305 - Tripeptides, their esters and amides, and anti-ulcera activity thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…